What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Disease
Johnny Ludvigsson mainly focuses on Diabetes mellitus, Type 1 diabetes, Internal medicine, Pediatrics and Endocrinology.
The concepts of his Diabetes mellitus study are interwoven with issues in Surgery, Incidence, Adverse effect, Insulin and Immunopathology.
His Type 1 diabetes research is multidisciplinary, incorporating elements of Hypoglycemia, Young adult, Immunology, Meta-analysis and Enterovirus.
His Internal medicine research incorporates themes from Research design and Placebo.
His research investigates the connection between Pediatrics and topics such as Cohort that intersect with issues in Cohort study.
His research in Endocrinology intersects with topics in Gastroenterology, Etiology and Physiology.
His most cited work include:
- Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins (501 citations)
- GAD treatment and insulin secretion in recent-onset type 1 diabetes (423 citations)
- Declining incidence of nephropathy in insulin-dependent diabetes mellitus (392 citations)
What are the main themes of his work throughout his whole career to date?
Johnny Ludvigsson spends much of his time researching Type 1 diabetes, Diabetes mellitus, Internal medicine, Immunology and Endocrinology.
Johnny Ludvigsson interconnects Odds ratio, Clinical trial, MEDLINE, Autoantibody and Disease in the investigation of issues within Type 1 diabetes.
Johnny Ludvigsson has included themes like Surgery, Incidence, Insulin and Pediatrics in his Diabetes mellitus study.
His work focuses on many connections between Pediatrics and other disciplines, such as Cohort study, that overlap with his field of interest in Cohort.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Antibody.
His Endocrinology research incorporates elements of Juvenile and Cytokine.
He most often published in these fields:
- Type 1 diabetes (49.84%)
- Diabetes mellitus (46.97%)
- Internal medicine (39.65%)
What were the highlights of his more recent work (between 2014-2021)?
- Type 1 diabetes (49.84%)
- Diabetes mellitus (46.97%)
- Internal medicine (39.65%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Type 1 diabetes, Diabetes mellitus, Internal medicine, Pediatrics and Immunology.
His Type 1 diabetes study incorporates themes from Incidence, Autoantibody, Insulin, Islet and Disease.
His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Retrospective cohort study, Cohort study and MEDLINE.
His Cohort study study also includes
- Risk factor which intersects with area such as Cohort and Odds ratio,
- Demography that connect with fields like Absolute risk reduction.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Endocrinology.
Pediatrics is closely attributed to Prospective cohort study in his work.
Between 2014 and 2021, his most popular works were:
- Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. (386 citations)
- Environmental risk factors for type 1 diabetes (257 citations)
- Detection of a Low-Grade Enteroviral Infection in the Islets of Langerhans of Living Patients Newly Diagnosed With Type 1 Diabetes (161 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Diabetes mellitus
Johnny Ludvigsson mainly investigates Type 1 diabetes, Diabetes mellitus, Immunology, Internal medicine and Autoimmunity.
The concepts of his Type 1 diabetes study are interwoven with issues in Young adult, Incidence, Pediatrics and MEDLINE.
Specifically, his work in Diabetes mellitus is concerned with the study of Islet.
His Immunology study combines topics in areas such as Pharmacotherapy and Disease.
Johnny Ludvigsson interconnects Gastroenterology, Endocrinology and Phenotype in the investigation of issues within Internal medicine.
His research in Endocrinology intersects with topics in Pilot trial and IL-2 receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
